NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $347,253 | +1.1% | 3,409 | +0.2% | 0.16% | +10.3% |
Q2 2023 | $343,409 | +9.7% | 3,403 | -0.0% | 0.15% | +0.7% |
Q1 2023 | $313,179 | +0.9% | 3,404 | -0.5% | 0.14% | -2.7% |
Q4 2022 | $310,455 | +19.4% | 3,422 | -0.0% | 0.15% | +4.9% |
Q3 2022 | $260,000 | -13.0% | 3,423 | -3.3% | 0.14% | -10.7% |
Q2 2022 | $299,000 | -4.5% | 3,540 | -0.7% | 0.16% | +22.3% |
Q1 2022 | $313,000 | +3.3% | 3,565 | +3.0% | 0.13% | +6.6% |
Q4 2021 | $303,000 | +7.4% | 3,461 | +0.4% | 0.12% | +0.8% |
Q3 2021 | $282,000 | -9.9% | 3,446 | +0.6% | 0.12% | +65.8% |
Q2 2021 | $313,000 | -49.0% | 3,427 | -52.3% | 0.07% | -44.3% |
Q1 2021 | $614,000 | -8.6% | 7,192 | +1.2% | 0.13% | -22.0% |
Q4 2020 | $672,000 | -5.1% | 7,108 | -12.7% | 0.17% | -13.0% |
Q3 2020 | $708,000 | -4.3% | 8,144 | -3.8% | 0.19% | -6.8% |
Q2 2020 | $740,000 | -2.0% | 8,466 | -7.5% | 0.21% | -5.0% |
Q1 2020 | $755,000 | -16.0% | 9,157 | -3.6% | 0.22% | -6.0% |
Q4 2019 | $899,000 | – | 9,497 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |